There is one approved therapy for CSU, Novartis injectable antibody Xolair (omalizumab), which got a green light for the condition in 2014, and there is a lot of interest in oral therapies that ...

it’s been said that the French government also contributed to the acquisition by encouraging Sanofi-Synthélabo to increase its bid after hearing that Swiss pharmaceutical company Novartis was ...

Uncertainty surrounding US tariffs and global economic headwinds has tempered hiring in India's pharma and healthcare GCCs.